MacroGenics, Inc.
MGNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $204 | $596 | $412 | $962 |
| - Cash | $183 | $101 | $109 | $123 |
| + Debt | $37 | $34 | $35 | $25 |
| Enterprise Value | $58 | $529 | $338 | $864 |
| Revenue | $148 | $57 | $150 | $76 |
| % Growth | 159.4% | -61.9% | 98.3% | – |
| Gross Profit | $136 | $49 | $143 | $73 |
| % Margin | 91.7% | 85.6% | 95.1% | 96.5% |
| EBITDA | -$57 | $2 | -$108 | -$191 |
| % Margin | -38.7% | 3.5% | -71.9% | -252.3% |
| Net Income | -$67 | -$9 | -$120 | -$202 |
| % Margin | -45.1% | -15.8% | -79.8% | -267.2% |
| EPS Diluted | -1.07 | -0.15 | -1.95 | -3.18 |
| % Growth | -613.3% | 92.3% | 38.7% | – |
| Operating Cash Flow | -$68 | -$78 | -$87 | -$144 |
| Capital Expenditures | -$4 | -$2 | -$4 | -$6 |
| Free Cash Flow | -$72 | -$80 | -$91 | -$150 |